Poly(lactic acid)/β-cyclodextrin based nanoparticles bearing ruthenium(II)-arene naproxen complex : preparation and characterisation. Analytical validation for metal determination by microwave-induced plasma optical emission spectrometry

The objectives of this work are to develop nanocarrier systems for the Ru(II)-p-cymene naproxen antitumor metallodrug, [Ru(η6-p-cymene)(npx)Cl] or Rupcy, based on polymeric nanoparticles (NPs) composed by the biodegradable poly(lactic acid) (PLA) and the hydrophilic polymerised β-cyclodextrin (PolyCD); to validate an analytical method for determination of Ru incorporated into the metallodrug loaded-NPs. The PolyCD was prepared by single step condensation and polymerisation reaction and incorporated as a polymer blend during the fabrication of PLA/PolyCD blends NPs and also as a core/shell structure built by adsorption of the PolyCD onto the surface of PLA NPs to give PLA(core)/PolyCD(shell) NPs. Three different loaded-systems incorporating the metallodrug (Rupcy-PLA NPs (1), Rupcy-PLA/PolyCD blends (2), and Rupcy-PLA(core)/PolyCD(shell) NPs (3)) were prepared by nanoprecipitation. The characterisation was performed by Proton Nuclear Magnetic Resonance, Matrix Assisted Laser Desorption/Ionization Time-of-Flight, Fourier-Transform Infra-red and UV-VIS Electronic Absorption Spectroscopies, Thermogravimetric Analysis, Differential Scanning Calorimetry, Dynamic Light Scattering, and Electrophoretic Light Scattering. Ru was determined by Microwave Induced Plasma Optical Emission Spectrometry (MIP-OES) with validation of the method. The metallodrug entrapment efficiency was around 90% (w/w) and drug loading was at 3-4% (w/w). The characterised metallodrug-loaded systems exhibited monomodal size distributions and appropriate hydrodynamic diameters [218.3 ± 13.5 (1), 205.4 ± 14.4 (2), 231.5 ± 22.0 (3) nm] and zeta potential values [-31.5 ± 2.2 (1), -26.1 ± 4.5 (2), -28.8 ± 6.1 (3) mV]. The validation of the MIP-OES method by evaluating selectivity, linearity, precision, accuracy, and limits of detection and quantification succeeded. The NPs parameters are compatible with colloidally stable systems. The MIP-OES method showed to be simple, reliable, and feasible to quantify indirectly the amount of the metallodrug-loaded into the PLA NPs.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:40

Enthalten in:

Journal of microencapsulation - 40(2023), 2 vom: 03. März, Seite 67-81

Sprache:

Englisch

Beteiligte Personen:

Reis Nascimento, Ruan [VerfasserIn]
Pauline Gaitan Tabares, Julie [VerfasserIn]
Marques Dos Anjos, Paulo Neilson [VerfasserIn]
Santos, Luana Novaes [VerfasserIn]
de Oliveira Silva, Denise [VerfasserIn]
Silva Ribeiro Santos, Rodrigo Luis [VerfasserIn]

Links:

Volltext

Themen:

1G1C8T1N7Q
4-cymene
459TN2L5F5
57Y76R9ATQ
7UI0TKC3U5
Anti-inflammatory drugs
Biodegradable polymers
Drug Carriers
Drug delivery systems
Journal Article
Metallodrug
Microwave-induced plasma
Naproxen
Poly(lactide)
Polyesters
Polymers
Ruthenium

Anmerkungen:

Date Completed 27.03.2023

Date Revised 27.03.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/02652048.2023.2172469

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM352330465